Literature DB >> 21458259

Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.

Jingying Liu1, Lin Zhu, Karl Plössl, Brian P Lieberman, Hank F Kung.   

Abstract

A series of novel N-fluoropyridyl-containing tropane derivatives were synthesized and their binding affinities for the dopamine transporter (DAT), serotonin transporter (SERT) and norepinephrine (NET) were determined via competitive radioligand binding assays. Among these derivatives, compound 6d showed the highest binding affinity to DAT (K(i)=4.1 nM), and selectivity for DAT over SERT (5-fold) and NET (16-fold). Compound 6d was radiolabeled with Fluorine-18 in two steps. Regional brain distribution and ex vivo autoradiography studies of [(18)F]6d demonstrated that the ligand was selectively localized in the striatum region, where DAT binding sites are highly expressed. [(18)F]6d may be useful as a potential radioligand for imaging DATs with PET.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458259      PMCID: PMC3085641          DOI: 10.1016/j.bmcl.2011.03.051

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  24 in total

1.  Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.

Authors:  Andrea Varrone; Miklós Tóth; Carsten Steiger; Akihiro Takano; Denis Guilloteau; Masanori Ichise; Balázs Gulyás; Christer Halldin
Journal:  J Nucl Med       Date:  2011-01       Impact factor: 10.057

2.  In vivo evaluation of [11C]- and [18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography.

Authors:  A A Wilson; J N DaSilva; S Houle
Journal:  Nucl Med Biol       Date:  1996-02       Impact factor: 2.408

3.  In vivo evaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography.

Authors:  S M Aquilonius; K Bergström; S A Eckernäs; P Hartvig; K L Leenders; H Lundquist; G Antoni; A Gee; A Rimland; J Uhlin
Journal:  Acta Neurol Scand       Date:  1987-10       Impact factor: 3.209

4.  18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.

Authors:  M M Goodman; C D Kilts; R Keil; B Shi; L Martarello; D Xing; J Votaw; T D Ely; P Lambert; M J Owens; V M Camp; E Malveaux; J M Hoffman
Journal:  Nucl Med Biol       Date:  2000-01       Impact factor: 2.408

5.  [11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations.

Authors:  L Müller; C Halldin; L Farde; P Karlsson; H Hall; C G Swahn; J Neumeyer; Y Gao; R Milius
Journal:  Nucl Med Biol       Date:  1993-04       Impact factor: 2.408

6.  N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

Authors:  J L Neumeyer; S Wang; Y Gao; R A Milius; N S Kula; A Campbell; R J Baldessarini; Y Zea-Ponce; R M Baldwin; R B Innis
Journal:  J Med Chem       Date:  1994-05-27       Impact factor: 7.446

Review 7.  Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents.

Authors:  Rikki N Waterhouse
Journal:  Mol Imaging Biol       Date:  2003 Nov-Dec       Impact factor: 3.488

8.  [18F]CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats.

Authors:  M Haaparanta; J Bergman; A Laakso; J Hietala; O Solin
Journal:  Synapse       Date:  1996-08       Impact factor: 2.562

9.  Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

Authors:  J J Frost; A J Rosier; S G Reich; J S Smith; M D Ehlers; S H Snyder; H T Ravert; R F Dannals
Journal:  Ann Neurol       Date:  1993-09       Impact factor: 10.422

10.  Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.

Authors:  Margaret R Davis; John R Votaw; J Douglas Bremner; Michael G Byas-Smith; Tracy L Faber; Ronald J Voll; John M Hoffman; Scott T Grafton; Clinton D Kilts; Mark M Goodman
Journal:  J Nucl Med       Date:  2003-06       Impact factor: 10.057

View more
  2 in total

1.  Radiosynthesis and validation of ¹⁸F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain.

Authors:  Paul Cumming; Simone Maschauer; Patrick J Riss; Nuska Tschammer; Stefanie K Fehler; Markus R Heinrich; Torsten Kuwert; Olaf Prante
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-09       Impact factor: 6.200

Review 2.  18F-labelled intermediates for radiosynthesis by modular build-up reactions: newer developments.

Authors:  Johannes Ermert
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.